News
Coking wastewater contains not only high-strength nitrogen but also toxic biorefractory organics. This study presents simultaneous removal of high-strength quinoline, carbon, and ammonium in coking ...
VIDEO: KITE-363 demonstrates response in patients with relapsed, refractory B-cell lymphoma - Healio
CHICAGO — In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses KITE-363, an anti-CD19/CD20 chimeric antigen receptor T-cell therapy, being studied for patients ...
Monjuvi in combination with lenalidomide and rituximab significantly improved PFS in patients with relapsed/refractory follicular lymphoma. The Food and Drug Administration (FDA) has approved ...
Chimeric antigen receptor (CAR) T-cell therapy may improve the health-related quality of life (HR-QoL) scores of patients with relapsed or refractory multiple myeloma (MM) who have received at ...
LEVERKUSEN, Germany— Covestro A.G. 's plan to work with its customers on the future of coatings and adhesives is becoming more of a reality with the opening of its new highly automated laboratory.
Pompano Beach, FL 33064 US Phone: (954) 782-2221 About Adhesives Technology Corp.
The adhesive, according to its developers, is made from xylan, which is a complex sugar found in plant cell walls. The adhesive’s developers suggest that it can be applied in a molten state and reused ...
Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...
Soft grippers can be used to grasp objects with various geometric surface structures or stiffness but typically encounter difficulty in providing high grasping force. Although the combination of soft ...
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. Due to the development of drug resistance to traditional chemotherapies and high relapse rate, AML still has a low ...
Could Johnson & Johnson’s Trispecific Antibody Redefine Treatment for Relapsed or Refractory Multiple Myeloma? “The response rate with JNJ-5322 is encouraging as we explore the potential of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results